Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty

Not Applicable

Completed

• Conditions: Healthy elderly subjects

• Registration Number: JPRN-UMIN000044496
• Lead Sponsor: Meiji Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-12
• Study Completion: 2022-03-18
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 77

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who have diagnosed with dementia, malignant tumor, chronic renal failure or diabetes 2) Subjects who have significant abnormal blood test score 3) Subjects who are prescribed antipsychotics, dementia treatment drugs, ethyl icosapentaebiate or omega 3-fatty acid ethyl 4) Subjects taking supplements that are expected to improve brain function more than 4 days a week 5) Subjects taking supplements containing EPA and/or DHA more than 4 days a week 6) Subjects who are prescribed anticoagulants and antiplatelet drugs. 7) Subjects who have milk allergy or lactose intolerance 8) Subjects who have soy allergy 9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period 10)Subjects who determine ineligible by the principal investigator or sub-investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified